Cargando…
Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview
Colorectal carcinoma is the second leading cause of cancer-related deaths, and indeed, rectal cancer accounting for approximately one third of newly diagnosed patients. Gold standard in the treatment of rectal cancer is a multimodality approach, aiming at a good control of the local disease. Distant...
Autores principales: | Guida, Andrea M., Sensi, Bruno, Formica, Vincenzo, D’Angelillo, Rolando M., Roselli, Mario, Del Vecchio Blanco, Giovanna, Rossi, Piero, Capolupo, Gabriella T., Caricato, Marco, Sica, Giuseppe S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195214/ https://www.ncbi.nlm.nih.gov/pubmed/35698084 http://dx.doi.org/10.1186/s13062-022-00329-7 |
Ejemplares similares
-
Factors Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer: The Experience of a Single Institution with 269 Patients (STONE-01)
por: Fiore, Michele, et al.
Publicado: (2021) -
Total neoadjuvant treatment in locally advanced rectal cancer
por: De Felice, Francesca, et al.
Publicado: (2021) -
Sentinel lymph node mapping procedure in T1 colorectal cancer: A systematic review of published studies
por: Di Berardino, Stefano, et al.
Publicado: (2019) -
TaTME approach as a rescue during a laparoscopic TME for high rectal cancer. A case report
por: Carannante, F., et al.
Publicado: (2021) -
Age and comorbidities do not affect short-term outcomes after laparoscopic rectal cancer resection in elderly patients. A multi-institutional cohort study in 287 patients
por: Peltrini, Roberto, et al.
Publicado: (2021)